
THIS HYBRID DEVICE INTEGRATES A MICROFLUIDIC CHIP FOR SAMPLE PREPARATION AND AN OPTOFLUIDIC CHIP FOR OPTICAL DETECTION OF INDIVIDUAL MOLECULES OF VIRAL RNA.
CREDIT: JOSHUA PARKS
Hybrid device integrates a microfluidic chip for sample preparation and an optofluidic chip for optical detection of individual molecules of viral RNA
A team led by researchers at UC Santa Cruz has developed chip-based technology for reliable detection of Ebola virus and other viral pathogens. The system uses direct optical detection of viral molecules and can be integrated into a simple, portable instrument for use in field situations where rapid, accurate detection of Ebola infections is needed to control outbreaks.
Laboratory tests using preparations of Ebola virus and other hemorrhagic fever viruses showed that the system has the sensitivity and specificity needed to provide a viable clinical assay. The team reported their results in a paper published September 25 in Nature Scientific Reports.
An outbreak of Ebola virus in West Africa has killed more than 11,000 people since 2014, with new cases occurring recently in Guinea and Sierra Leone. The current gold standard for Ebola virus detection relies on a method called polymerase chain reaction (PCR) to amplify the virus’s genetic material for detection. Because PCR works on DNA molecules and Ebola is an RNA virus, the reverse transcriptase enzyme is used to make DNA copies of the viral RNA prior to PCR amplification and detection.
“Compared to our system, PCR detection is more complex and requires a laboratory setting,” said senior author Holger Schmidt, the Kapany Professor of Optoelectronics at UC Santa Cruz. “We’re detecting the nucleic acids directly, and we achieve a comparable limit of detection to PCR and excellent specificity.”
In laboratory tests, the system provided sensitive detection of Ebola virus while giving no positive counts in tests with two related viruses, Sudan virus and Marburg virus. Testing with different concentrations of Ebola virus demonstrated accurate quantification of the virus over six orders of magnitude. Adding a “preconcentration” step during sample processing on the microfluidic chip extended the limit of detection well beyond that achieved by other chip-based approaches, covering a range comparable to PCR analysis.
“The measurements were taken at clinical concentrations covering the entire range of what would be seen in an infected person,” Schmidt said.
Schmidt’s lab at UC Santa Cruz worked with researchers at Brigham Young University and UC Berkeley to develop the system. Virologists at Texas Biomedical Research Institute in San Antonio prepared the viral samples for testing.
The system combines two small chips, a microfluidic chip for sample preparation and an optofluidic chip for optical detection. For over a decade, Schmidt and his collaborators have been developing optofluidic chip technology for optical analysis of single molecules as they pass through a tiny fluid-filled channel on the chip. The microfluidic chip for sample processing can be integrated as a second layer next to or on top of the optofluidic chip.
Schmidt’s lab designed and built the microfluidic chip in collaboration with coauthor Richard Mathies at UC Berkeley who pioneered this technology. It is made of a silicon-based polymer, polydimethylsiloxane (PDMS), and has microvalves and fluidic channels to transport the sample between nodes for various sample preparation steps. The targeted molecules–in this case, Ebola virus RNA–are isolated by binding to a matching sequence of synthetic DNA (called an oligonucleotide) attached to magnetic microbeads. The microbeads are collected with a magnet, nontarget biomolecules are washed off, and the bound targets are then released by heating, labeled with fluorescent markers, and transferred to the optofluidic chip for optical detection.
Schmidt noted that the team has not yet been able to test the system starting with raw blood samples. That will require additional sample preparation steps, and it will also have to be done in a biosafety level 4 facility.
Read more: Chip-based technology enables reliable direct detection of Ebola virus
The Latest on: Ebola detection
[google_news title=”” keyword=”Ebola detection” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Ebola detection
- Nutritional Care for Patients With Ebola Virus Diseaseon June 6, 2023 at 4:59 pm
During the Ebola virus disease (EVD) outbreak of 2014–2016 in West Africa, practitioners faced challenges providing nutritional care for patients in Ebola treatment units (ETUs). The current EVD ...
- Ebola's exponential growthon June 6, 2023 at 4:59 pm
Here are three bad things about Ebola. The “bodily fluids” that ... but it is still in an early stage of testing. Human volunteers are now being given the vaccine to check for unforeseen ...
- Citizen Science: lessons in pandemic preparedness from Sierra Leoneon June 2, 2023 at 2:19 am
Our research explored how communities responded to two epidemics in Sierra Leone. Here we highlight some of our findings, emphasising the importance of taking note of what communities themselves infer ...
- Perspectives on West Africa Ebola Virus Disease Outbreak, 2013–2016on June 1, 2023 at 5:00 pm
detection, and response. These factors include occurrence in a region recovering from civil instability and lacking experience with Ebola response; inadequate surveillance, recognition of ...
- Rights, responsibility and reassurance on Ebolaon May 30, 2023 at 10:30 pm
Though he has no symptoms, he worked in Liberia with Ebola patients until recently. Stanford Health Care For the last seven days, since he returned from a Liberian clinic, Dr. Colin Bucks has been ...
- Imminent Threat of the Next Pandemic - Disease Xon May 28, 2023 at 11:28 am
Despite a decline in COVID-19 cases, the World Health Organisation (WHO) raises global concerns by warning of an 'inevitable' next pandemic known as 'Disease X'.
- Ebola Outbreak Puts the Spotlight on 10 Biotech Companieson May 24, 2023 at 5:00 pm
The Ebola outbreak has put the spotlight on Chimerix as well as other biotech companies with potential vaccines and even those stocks with marginal relation to the virus. The Ebola outbreak has ...
- African scientists are working to pool data that decodes diseases – a giant stepon May 21, 2023 at 12:25 am
Ebola in the Democratic Republic of the Congo or Uganda ... It also helps public health authorities to guide and prepare their public health systems for effective outbreak detection and response.
- Ebola virus: from discovery to vaccineon May 19, 2023 at 9:59 am
Ebola virus, being highly pathogenic for humans and non-human primates and the subject of former weapons programmes, is now one of the most feared pathogens worldwide. In addition, the lack of pre ...
- Ebola As ISIS Bio-Weapon?on May 1, 2023 at 4:45 am
I cover aerospace, astronomy and host The Cosmic Controversy Podcast. ISIS may already be thinking of using Ebola as a low-tech weapon of bio-terror, says a national security expert, who notes ...
via Bing News